In an unusual move, Allergan has touted a study detailing its many contributions to the economy in Waco, Texas, where the drug maker has a manufacturing facility. And the results could be used to bolster its case in Washington, D.C. for approval of its controversial merger with Pfizer.
Read Full Article »
